Quick Answer
CTT PHARMACEUTICAL HOLDINGS, INC. reported Net Income of $227.8 thousand for fiscal year 2014.
CTT PHARMACEUTICAL HOLDINGS, INC. — Key Financials by Year
| Metric | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|
| Net Income | $227.8K +1304.8% |
-$18.9K +98.1% |
-$1.00M -126.8% |
$3.74M +440.6% |
-$1.10M | — |
| Diluted EPS | — | $0.01 +109.1% |
-$0.11 -127.5% |
$0.40 +407.7% |
-$0.13 | — |
| Total Assets | $1.66M +26489.4% |
$6.3K -96.9% |
$203.1K -95.1% |
$4.18M +231.4% |
$1.26M | — |
| Cash and Equivalents | $81.2K +9763.8% |
$823.00 -93.2% |
$12.1K -97.9% |
$569.4K +1132.7% |
$46.2K -83.0% |
$271.2K |
| Stockholders Equity | $586.6K +2100.6% |
-$29.3K -46.6% |
-$20.0K -104.4% |
$456.4K +33811.6% |
$1.3K +100.1% |
-$1.25M -924.8% |
| Operating Income | — | $92.2K +107.7% |
-$1.19M -57.7% |
-$757.9K +63.4% |
-$2.07M | — |
| Shares Outstanding | 195.07M +30.8% |
149.18M +1504.0% |
9.30M +0.0% |
9.30M -94.3% |
163.25M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2015 | -$341.9K | -691.6% | +5.7% |
| Diluted EPS | June 30, 2014 | $0.00 | +100.0% | — |
| Total Assets | September 30, 2015 | $922.0K | +605.2% | -22.1% |
| Cash and Equivalents | September 30, 2015 | $32.1K | -74.4% | -30.3% |
| Stockholders Equity | September 30, 2015 | $738.1K | +11905.2% | -25.2% |
| Operating Income | June 30, 2014 | -$22.3K | +64.3% | +17.9% |
| Shares Outstanding | September 30, 2015 | 21.32M | -88.4% | -90.0% |
- CTT PHARMACEUTICAL HOLDINGS, INC. reported Net Income of $227.8 thousand for fiscal year 2014.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +1304.8% in Net Income compared to the prior fiscal year.
- CTT PHARMACEUTICAL HOLDINGS, INC. reported Diluted EPS of $0.01 per share for fiscal year 2013.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +109.1% in Diluted EPS compared to the prior fiscal year.
- CTT PHARMACEUTICAL HOLDINGS, INC. reported Total Assets of $1.66 million for fiscal year 2014.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +26489.4% in Total Assets compared to the prior fiscal year.
- CTT PHARMACEUTICAL HOLDINGS, INC. reported Cash and Equivalents of $81.2 thousand for fiscal year 2014.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +9763.8% in Cash and Equivalents compared to the prior fiscal year.
- CTT PHARMACEUTICAL HOLDINGS, INC. reported Stockholders Equity of $586.6 thousand for fiscal year 2014.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +2100.6% in Stockholders Equity compared to the prior fiscal year.
- CTT PHARMACEUTICAL HOLDINGS, INC. reported Operating Income of $92.2 thousand for fiscal year 2013.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +107.7% in Operating Income compared to the prior fiscal year.
- CTT PHARMACEUTICAL HOLDINGS, INC. reported Shares Outstanding of 195.07 million shares for fiscal year 2014.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +30.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: